No Record Found
Sector
PharmaceuticalsOpen
₹1,900.1Prev. Close
₹1,972.8Turnover(Lac.)
₹11,637.41Day's High
₹1,989Day's Low
₹1,88052 Week's High
₹2,13152 Week's Low
₹1,277.8Book Value
₹608.44Face Value
₹1Mkt Cap (₹ Cr.)
32,260.95P/E
28.6EPS
68.96Divi. Yield
0.9120 May 2025
12:00 AM
AGM
Announcement Date: 20 May, 2025
20 May 2025
12:00 AM
Dividend
Dividend Amount: 18
Record Date: 14 Aug, 2025
21 Jul 2025
12:00 AM
Board Meeting
Agenda : Audited Result
Here are some of the stocks that may see significant price movement today: Avenue Supermarts, BEML, Gland Pharma, etc.
The receipt of the EIR marks the formal closure of the US health regulator’s pre-approval inspection, which was conducted between February 19 and February 25, 2025.
Here are some of the stocks that may see significant price movement today: Hindustan Aeronautics, Gland Pharma, REC, etc.
Gland Pharma also established that its version is bioequivalent and therapeutically equivalent to the reference listed drug.
Gland Pharma net profit was at ₹186.5 crore as against ₹192.4 crore in the year-ago quarter of FY24.
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 16.48 | 16.47 | 16.47 | 16.51 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 9,738.63 | 8,978.82 | 7,936.83 | 7,141.72 |
Net Worth | 9,755.11 | 8,995.29 | 7,953.3 | 7,158.23 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2017 |
|---|---|---|---|
Revenue | 4,400.7 | 3,462.87 | 1,479.17 |
yoy growth (%) | 27.08 | 134.1 | |
Raw materials | -2,109.21 | -1,491.87 | -509.73 |
As % of sales | 47.92 | 43.08 | 34.46 |
Employee costs | -338.56 | -311.36 | -153.41 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2017 |
|---|---|---|---|
Profit before tax | 1,619.04 | 1,334.85 | 578.01 |
Depreciation | -110.29 | -98.78 | -74.14 |
Tax paid | -406.88 | -337.84 | -164.28 |
Working capital | 496.99 | 3,455.68 | |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2017 |
|---|---|---|---|
Growth matrix (%) | |||
Revenue growth | 27.08 | 134.1 | |
Op profit growth | 16 | 108.36 | |
EBIT growth | 21.37 | 128.99 | |
Net profit growth | 21.57 | 140.98 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 5,616.5 | 5,664.72 | 3,624.6 | 4,400.71 | 3,462.88 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 5,616.5 | 5,664.72 | 3,624.6 | 4,400.71 | 3,462.88 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 213.61 | 170.24 | 240.46 | 223.94 | 134.78 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,586.7 | 78.42 | 3,90,611.73 | 753.53 | 0.98 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 5,689.5 | 67.03 | 1,56,589.3 | 557 | 0.51 | 2,357 | 561.08 |
Cipla Ltd CIPLA | 1,499.4 | 23.61 | 1,21,954.71 | 1,303.13 | 1.06 | 4,501.66 | 397.38 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,561 | 60.14 | 1,19,555.56 | 551 | 0.17 | 2,567 | 224.34 |
Dr Reddys Laboratories Ltd DRREDDY | 1,253.1 | 15.44 | 1,06,396.56 | 2,961.2 | 0.63 | 7,788.7 | 345.74 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman / Executive Director / MD / CEO
SRINIVAS SADU
Independent Non Exe. Director
UDO JAHANNES VETTER
Independent Non Exe. Director
Satyanarayana Murthy Chavali
Independent Non Exe. Director
ESSAJI GOOLAM VAHANVATI
Non-Exec & Non-Independent Dir
Jia Ai (Allen) Zhang
Independent Non Exe. Director
Naina Lal Kidwai
Non-Exec & Non-Independent Dir
Wenjie Zhang
Non-Exec & Non-Independent Dir
Wei Huang
CS / Compliance Officer / Vice President
SAMPATH KUMAR PALLERLAMUDI
Sy No 143-148 150&151 Nr Gandi,
X Roads D P Pally Dundigal,
Telangana - 500043
Tel: 91-40-30510999
Website: http://www.glandpharma.com
Email: investors@glandpharma.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Gland Pharma Limited was incorporated as Gland Pharma Private Limited, a private limited company on March 20, 1978 and was granted the certificate of incorporation by Registrar of Companies, Andhra Pr...
Read More
Reports by Gland Pharma Ltd
What is the Gland Pharma Ltd share price today?
What is the Market Cap of Gland Pharma Ltd?
What is the PE and PB ratio of Gland Pharma Ltd?
What is the 52 Week High and Low of Gland Pharma Ltd?
What is the CAGR of Gland Pharma Ltd?
What is the shareholding pattern of Gland Pharma Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
